Abstract
Fungal infections causing deep tissue involvement are known as trichophytic granulomas. We describe an unusual case of trichophytic granuloma presenting in the vulva of a 39-year-old woman.
References
1.
Arnold HL, Odom RB, James WD: Andrew’s Diseases of the Skin: Clinical Dermatology, ed. 8. Philadelphia, Saunders, 1990, pp 300–301.
2.
Reynolds RD, Boiko S, Lucky AW: Exacerbation of tinea corporis during treatment with 1% clotrimazole/0.05% betamethasone diproprionate (lotrisone). Am J Dis Child 1991;145: 1224–1225.
3.
Barkey WF: Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (lotrisone cream). J Am Acad Dermatol 1987;17:518–519.
4.
Smith EB, Brenenman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, et al.: Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis. J Am Acad Dermatol 1992;26:125–127.
5.
Elmets CA: Management of common superficial fungal infections in patients with AIDS. J Am Acad Dermatol 1994;31:S60–S63.
6.
Radentz WH, Yanase DJ: Papular lesions in an immunocompromised patient: Trichophyton rubrum granulomas (Majocchi’s granuloma). Arch Dermatol 1993;129:1189–1190.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
